معرفی
Xiao-Feng Yang, MD, PhD, FAHA is a Professor and Associate Director at the Lemole Center for Integrated Lymphatics and Vascular Research at Temple University's Lewis Katz School of Medicine. He holds multiple professorial appointments across departments including Cardiovascular Sciences, Microbiology, Immunology and Inflammation, and Biomedical Education and Data Science. His research focuses on epigenetic mechanisms in cardiovascular diseases (CVD), particularly how CVD risk factors influence histone modification and gene expression in vascular inflammation and atherosclerosis.
Education: MD from JiangXi Medical University (1979), MS in Immunology from Chinese National Academy of Medical Sciences (1982), PhD in Biochemistry from University of Montreal (1994), and fellowship training in Immunology at Harvard Medical School (1999).
Research interests span epigenetic pathology, metabolic disease pathways, thrombosis, and vascular immunology. Notable contributions include studies on metabolic crosstalk in metabolic syndrome, lysophospholipid signaling in atherosclerosis, and regulatory T cell epigenetics. His work integrates basic science with translational medicine, addressing mechanisms of vascular inflammation and therapeutic targets.
Awards include Fellow of the American Heart Association (FAHA). Active in multiple research centers including the Sol Sherry Thrombosis Research Center and Center for Metabolic Disease Research. His publications (over 100) emphasize interdisciplinary approaches to cardiovascular and metabolic disorders.
